» Articles » PMID: 35232671

Organoid Technologies for the Study of Intestinal Microbiota-host Interactions

Overview
Journal Trends Mol Med
Date 2022 Mar 2
PMID 35232671
Authors
Affiliations
Soon will be listed here.
Abstract

Postbiotics have recently emerged as critical effectors of the activity of probiotics and, because of their safety profile, they are considered potential therapeutics for the treatment of fragile patients. Here, we present recent studies on probiotics and postbiotics in the context of novel discovery tools, such as organoids and organoid-based platforms, and nontransformed preclinical models, that can be generated from intestinal stem cells. The implementation of organoid-related techniques is the next gold standard for unraveling the effect of microbial communities on homeostasis, inflammation, idiopathic diseases, and cancer in the gut. We also summarize recent studies on biotics in organoid-based models and offer our perspective on future directions.

Citing Articles

Microbes Saving Lives and Reducing Suffering.

Timmis K, Karahan Z, Ramos J, Koren O, Perez-Cobas A, Steward K Microb Biotechnol. 2025; 18(1):e70068.

PMID: 39844583 PMC: 11754571. DOI: 10.1111/1751-7915.70068.


Experimental models of antibiotic exposure and atopic disease.

Donald K, Finlay B Front Allergy. 2024; 5:1455438.

PMID: 39525399 PMC: 11543581. DOI: 10.3389/falgy.2024.1455438.


Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.

Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L MedComm (2020). 2024; 5(10):e735.

PMID: 39309690 PMC: 11416091. DOI: 10.1002/mco2.735.


Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening.

Yang Z, Yu J, Wong C Cells. 2024; 13(16.

PMID: 39195202 PMC: 11352269. DOI: 10.3390/cells13161312.


() : a probiotic candidate to reduce neonatal diarrhea in calves.

Schwaiger K, Storch J, Bauer C, Bauer J Front Microbiol. 2023; 14:1266905.

PMID: 37854332 PMC: 10579909. DOI: 10.3389/fmicb.2023.1266905.


References
1.
Kelleher S, Alam S, Rivera O, Barber-Zucker S, Zarivach R, Wagatsuma T . Loss-of-function mutants are associated with gut dysbiosis and alterations in intestinal gene expression in preterm infants. Gut Microbes. 2021; 14(1):2014739. PMC: 8726655. DOI: 10.1080/19490976.2021.2014739. View

2.
Naghmouchi K, Belguesmia Y, Bendali F, Spano G, Seal B, Drider D . : a bacterial species with potential for food preservation and biomedical applications. Crit Rev Food Sci Nutr. 2019; 60(20):3387-3399. DOI: 10.1080/10408398.2019.1688250. View

3.
Nickerson K, Llanos-Chea A, Ingano L, Serena G, Miranda-Ribera A, Perlman M . A Versatile Human Intestinal Organoid-Derived Epithelial Monolayer Model for the Study of Enteric Pathogens. Microbiol Spectr. 2021; 9(1):e0000321. PMC: 8552518. DOI: 10.1128/Spectrum.00003-21. View

4.
Kiela P, Ghishan F . Physiology of Intestinal Absorption and Secretion. Best Pract Res Clin Gastroenterol. 2016; 30(2):145-59. PMC: 4956471. DOI: 10.1016/j.bpg.2016.02.007. View

5.
Beyaz S, Mana M, Roper J, Kedrin D, Saadatpour A, Hong S . High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature. 2016; 531(7592):53-8. PMC: 4846772. DOI: 10.1038/nature17173. View